Guardant Health
GH
#2672
Rank
โ‚ฌ4.79 B
Marketcap
38,87ย โ‚ฌ
Share price
-4.25%
Change (1 day)
122.76%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2024 (TTM): -โ‚ฌ0.41 Billion

According to Guardant Health 's latest financial reports the company's current earnings are โ‚ฌ0.73 Billion. , an increase over its 2023 earnings that were of -โ‚ฌ0.46 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2024

Annual earnings

Year Earnings Change
2024 -โ‚ฌ0.42 Billion-9.12%
2023 -โ‚ฌ0.46 Billion-26.73%
2022 -โ‚ฌ0.63 Billion69.96%
2021 -โ‚ฌ0.37 Billion56.35%
2020 -โ‚ฌ0.24 Billion252.69%
2019 -โ‚ฌ66.53 Million-17.22%
2018 -โ‚ฌ80.36 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-โ‚ฌ0.21 Billion-51.17%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚ฌ0.49 Billion 15.93%๐Ÿ‡บ๐Ÿ‡ธ USA